New treatment available for Australians with leukaemia

From 1 December 2021, Australians with acute myeloid leukaemia (AML) will have access to a new treatment option on the Pharmaceutical Benefits Scheme (PBS). The

From 1 December 2021, Australians with acute myeloid leukaemia (AML) will have access to a new treatment option on the Pharmaceutical Benefits Scheme (PBS). The